Detalhe da pesquisa
1.
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.
Haematologica
; 105(3): 598-609, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248972
2.
Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia.
J Cell Immunol
; 4(1): 19-28, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052149
3.
Elastase inhibitors as potential therapies for ELANE-associated neutropenia.
J Leukoc Biol
; 102(4): 1143-1151, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754797